Tessari Eben bought KNSA
December 15, 2025 · Form 4 insider transaction
Tessari Eben bought 6,000 shares of Kiniksa Pharmaceuticals International, plc at $8.83 per share, a transaction worth $53.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$8.83
Total value
$53.0K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after28,714
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.